Differential ectonucleotidase expression in human bladder cancer cell lines

Urologic Oncology: Seminars and Original Investigations

Volumn 28, Issue 3, 2010, Pages 260-267

  Stella, Joséli ^a   Bavaresco, Luci ^a   Braganhol, Elizandra ^a   Rockenbach, Liliana ^a   Farias, Patrícia Fernandes ^a   Wink, Márcia R ^c   Azambuja, Alan A ^b   Barrios, Carlos Henrique ^b   Morrone, Fernanda Bueno ^b   Oliveira Battastini, Ana Maria ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

Author keywords

Bladder cancer; Ecto 5 nucleotidase; Ectonucleotidases; Purinergic signaling

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; ECTO 5' NUCLEOTIDASE; NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 3; NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 4; NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 5; PHOSPHODIESTERASE; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CANCER INVASION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL; PROTEIN HYDROLYSIS; TUMOR GROWTH;

5'-NUCLEOTIDASE; ADENOSINE TRIPHOSPHATASES; CELL LINE, TUMOR; HUMANS; ONCOGENE PROTEINS; PYROPHOSPHATASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; URINARY BLADDER NEOPLASMS;

EID: 77951623666     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2009.01.035     Document Type: Article

References (38)

1. Brauers A., and Jakse G. Epidemiology and biology of human urinary bladder cancer. J Cancer Res Clin Oncol 126 (2000) 575-583
2. Jemal A., Murray T., Ward E., et al. Cancer statistics. CA Cancer J Clin 55 (2005) 10-30
3. Przybylo M., Litynska A., and Pochec E. Different adhesion and migration properties of human HCV29 nonmalignant urothelial and T24 bladder cancer cell: Role of glycosylation. Biochimie 87 (2005) 133-142
4. Heney N.M., Ahmed S., Flanagan M.J., et al. Superficial bladder cancer: Progression and recurrence. J Urol 130 (1983) 1083-1086
5. Herr H.W., Wartinger W.R., Fair W.R., et al. Bacillus Calmette-Guerin therapy for superficial bladder cancer: A 10-year follow-up. J Urol 147 (1992) 1020-1023
6. Lamm D.L., Thor D.E., Harris S.C., et al. Bacillus Calmette-Guerin immunotherapy of superficial bladder cancer. J Urol 124 (1980) 38-40
7. Burnstock G. Introduction: P2 receptors. Curr Top Med Chem 4 (2004) 793-803
8. Burnstock G., and Knight G.E. Cellular distribution and functions of P2 receptor subtypes in different systems. Int Rev Cytol 240 (2004) 31-304
9. Zimmermann H. Ectonucleotidases: Some recent developments and a note on nomenclature. Drug Dev Res 52 (2001) 44-56
10. Zimmermann H. 5′-Nucleotidase-molecular structure and functional aspects. Biochem J 285 (1992) 345-365
11. Robson S.C., Sévigny J., and Zimmermann H. The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance. Purinergic Signal 2 (2006) 409-430
12. Dzhandzhugazyan K.N., Kirkin A.F., Straten P.T., et al. Ecto-ATP diphosphohydrolase/CD39 is overexpressed in differentiated human melanomas. FEBS Lett 430 (1998) 227-230
13. Kittel A., Garrido M., and Vargas G. Localization of NTPDase1/CD39 in normal and transformed human pancreas. J Histochem Cytochem 50 (2002) 549-555
14. Blanquez M.I., Areras M.I., Conde I., et al. Deregulated expression of the PCPH proto-oncogene in human breast cancers. Int J Oncology 4 (2004) 820-830
15. Ujházy P., Berleth E.S., Pietkiewicz J.M., et al. Evidence for the involvement of ecto-5′-nucleotidase (CD73) in drug resistance. Int J Cancer 68 (1996) 493-500
16. Spychala J. Tumor-promoting functions of adenosine. Pharmacol Ther 87 (2000) 161-173
17. Wink M.R., Lenz G., Braganhol E., et al. Altered extracellular ATP, ADP, and AMP catabolism in glioma cell lines. Cancer Lett 198 (2003) 211-218
18. Morrone F.B., Oliveira D.L., Gamermann P.W., et al. In vivo glioblastoma growth is reduced by apyrase activity in a rat glioma model. BMC Cancer 6 (2006) 226-231
19. Bavaresco L., Bernardi A., Braganhol E., et al. The role of ecto-5′-nucleotidase/CD73 in glioma cell line proliferation. Mol Cell Biochem 319 (2008) 61-68
20. Goding J.W., Grobben B., and Slegers H. Physiological and pathophysiological functions of ectonucleotide pyrophosphatase/phosphodiesterase family. Biochim Biophys Acta 1638 (2003) 1-19
21. Bollen M., Gijsbers R., Ceulemans H., et al. Nucleotide pyrophosphatases/phosphodiesterases on the move. Crit Rev Biochem Mol Biol 35 (2000) 393-432
22. Ashfaque A., Memon M.B.B.S., Chang J.W., et al. Identification of differentially expressed proteins during human urinary bladder cancer progression. Cancer Detect Prev 29 (2005) 249-255
23. 3 receptor expression in human bladder urothelium and changes in interstitial cystitis. BJU Int 93 (2004) 1344-1348
24. Burnstock G. Purine-mediated signaling in pain and visceral perception. Trends Pharmacol Sci 22 (2001) 182-188
25. Shabbir M., Ryten M., Thompson C., et al. Purinergic receptor-mediated effects of ATP in high-grade bladder cancer. BJU Int 01 (2007) 106-112
26. 2+-ATPase activity. Anal Biochem 157 (1986) 375-380
27. Sakura H., Nagashima S., Nakashima A., et al. Characterization of fetal serum 5′-nucleotide phosphodiesterase: A novel function as a platelet aggregation inhibitor in fetal circulation. Thromb Res 91 (1998) 83-89
28. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
29. Elneil S., Skepper J.N., Kidd E.J., et al. Distribution of P2X(1) and P2X(3) receptors in the rat and human urinary bladder. Pharmacology 63 (2001) 120-128
30. White N., and Burnstock G. P2 receptors and cancer. Trends Pharmacol Sci 27 (2006) 211-217
31. Phelps P.T., Anthes J.C., and Correl C.C. Characterization of adenosine receptors in the human bladder carcinoma T24 cell line. Eur J Pharmacol 536 (2006) 28-37
32. Stefan C., Jansen S., and Bollen M. NPP-type ectophosphodiesterases unity in diversity. Trends Biochem Sci 30 (2005) 542-550
33. Paez J.G., Recio J., Rouzaut A., et al. Identity between the PCPH proto-oncogene and the CD39L4 (NTPDase5) ectonucleoside triphosphate diphosphohydrolase gene. Int J Oncol 19 (2001) 1249-1254
34. Rouzaut A., Recio J.A., and Notario V. Expression of the protein product of the PCHP proto-oncogene in human tumor cell lines. Radiat Res 155 (2001) 181-187
35. Merighi S., Mirandola P., Varani K., et al. A glance at adenosine receptors: Novel target for antitumor therapy. Pharmacol Ther 100 (2003) 31-48
36. Zhou P., Zhi X., Zhou T., et al. Overexpression of ecto-5′-nucleotidase (CD73) promotes T-47D human breast cancer cells invasion and adhesion to extracellular matrix. Cancer Biol Ther 6 (2007) 426-431
37. Sadej R., Spychala J., and Skladanowski A.C. Expression of ecto-5′-nucleotidase (eN, CD73) in cell lines from various stages of human melanoma. Melanoma Res 16 (2006) 213-222
38. Burnstock G. Purinergic signaling and disorders of the central nervous s system. Nature Rev 7 (2008) 575-590